Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $0.46 in the prior trading day, Vaxxinity Inc (NASDAQ: VAXX) closed at $0.48, up 2.43%. In other words, the price has increased by $2.43 from its previous closing price. On the day, 0.39 million shares were traded. VAXX stock price reached its highest trading level at $0.48 during the session, while it also had its lowest trading level at $0.42.
Ratios:
Our goal is to gain a better understanding of VAXX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.89 and its Current Ratio is at 1.89. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 0.99.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on September 08, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 08 ’23 when Prime Movers Lab Fund I LP sold 25,089 shares for $1.67 per share. The transaction valued at 41,899 led to the insider holds 8,713,663 shares of the business.
Prime Movers Lab Fund I LP sold 22,872 shares of VAXX for $38,196 on Sep 08 ’23. The 10% Owner now owns 831,658 shares after completing the transaction at $1.67 per share. On Sep 07 ’23, another insider, Prime Movers Lab Fund I LP, who serves as the 10% Owner of the company, sold 20,312 shares for $1.79 each. As a result, the insider received 36,302 and left with 8,738,752 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VAXX now has a Market Capitalization of 60344724 and an Enterprise Value of 44876572.
Stock Price History:
Over the past 52 weeks, VAXX has reached a high of $3.10, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -29.73%, while the 200-Day Moving Average is calculated to be -61.46%.
Shares Statistics:
The stock has traded on average 441.04K shares per day over the past 3-months and 447990 shares per day over the last 10 days, according to various share statistics. A total of 112.87M shares are outstanding, with a floating share count of 45.31M. Insiders hold about 64.25% of the company’s shares, while institutions hold 9.91% stake in the company. Shares short for VAXX as of 1711584000 were 4084021 with a Short Ratio of 9.26, compared to 1709164800 on 3654126. Therefore, it implies a Short% of Shares Outstanding of 4084021 and a Short% of Float of 9.54.
Earnings Estimates
The performance of Vaxxinity Inc (VAXX) in the stock market is under the watchful eye of VXX analysts actively contributing to its current rating.The consensus estimate for the next quarter is $15.46, with high estimates of $6.89 and low estimates of $0.48.
